Hong Kong Integrated Oncology Centre ( Site 0232)

Central 0000

1 studies enrolling now · 1 studies all time

What they study most

Malignant Neoplasm

Studies at this site

• KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J) — Recruiting now